ENTITY
GC Biopharma Corp

GC Biopharma Corp (006280 KS)

103
Analysis
Health Care • South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
bullish•SK Bioscience
•07 Feb 2021 02:23

SK Bioscience IPO Preview - Biggest IPO in Korea in 1Q 2021

SK Bioscience is getting ready to complete its IPO in Korea in March. SK Bioscience will be the biggest IPO in Korea so far this year in 2021. The...

Logo
593 Views
Share
bullish•Quantitative Analysis
•06 Apr 2020 10:07

What Local Institutions Buy in KOSPI: Screening Low Capital Risk & High Div Stocks

What are the local institutions buying in KOSPI? Below is the top 20 list of the most purchased stocks (in terms of net bought value as a % of...

Logo
385 Views
Share
bullish•China Everbright
•07 Feb 2018 07:58

StubWorld - Set-Up & Unwind Extremes: China Everbright; Green Cross

This week: China Everbright Ltd (165 HK) is around the "cheapest" inside a year, with various opportunities to monetise assets expected in 2018;...

Logo
426 Views
Share
•02 Feb 2018 21:52

Enzychem Lifesciences New IPO Book Summary

Enzychem Lifesciences Corp (183490 KS) submitted the revised version of IPO book on Jan 22. Here is the link of this new IPO...

Logo
397 Views
Share
•21 Jan 2018 04:15

Enzychem Lifesciences IPO Rescheduling Summary

Enzychem Lifesciences Corp (183490 KS), which is Korea's first major and serious IPO this year, announced (around 6 PM Friday Jan 19) that it had...

Logo
403 Views
Share
x